Gene: ATG12
Official Full Name: autophagy related 12provided by HGNC
Gene Summary: Autophagy is a process of bulk protein degradation in which cytoplasmic components, including organelles, are enclosed in double-membrane structures called autophagosomes and delivered to lysosomes or vacuoles for degradation. ATG12 is the human homolog of a yeast protein involved in autophagy (Mizushima et al., 1998 [PubMed 9852036]).[supplied by OMIM, Mar 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO08162 | ATG12 Knockout cell line (HeLa) | Human | ATG12 | 1:3~1:6 | Negative | Online Inquiry |
KO08163 | ATG12 Knockout cell line (HCT 116) | Human | ATG12 | 1:2~1:4 | Negative | Online Inquiry |
KO08164 | ATG12 Knockout cell line (HEK293) | Human | ATG12 | 1:3~1:6 | Negative | Online Inquiry |
KO08165 | ATG12 Knockout cell line (A549) | Human | ATG12 | 1:3~1:4 | Negative | Online Inquiry |
ATG12 Gene Knockout Cell Lines are genetically modified cell lines specifically engineered to lack the expression of the ATG12 gene, a critical component of the autophagy pathway. Autophagy, a cellular process essential for the degradation of damaged organelles and proteins, plays a pivotal role in maintaining cellular homeostasis and responding to stress. By creating knockout models of the ATG12 gene, researchers can investigate the functional implications of impaired autophagy in various biological contexts, including cancer progression, neurodegenerative diseases, and metabolic disorders.
The mechanism by which ATG12 influences autophagy revolves around its involvement in the formation of autophagosomes, structures that encapsulate cellular debris for degradation. The absence of ATG12 disrupts this process, providing key insights into how autophagy regulation affects cellular responses to nutrient deprivation and the quality control of cellular components. As such, these knockout cell lines serve as invaluable tools for elucidating the roles of autophagy in various physiological and pathological states.
From a scientific standpoint, ATG12 Gene Knockout Cell Lines are instrumental in advancing research aimed at dissecting the intricacies of autophagy-related pathways and their implications in disease. They are particularly relevant in drug discovery settings, where understanding autophagy modulation can lead to novel therapeutic strategies.
When compared to alternative gene-editing techniques or wild-type cell lines, these knockout models offer specific advantages, including a well-characterized genetic alteration and reproducibility, making them more reliable for experimental applications. Researchers and clinicians can leverage ATG12 knockout lines for innovative studies, tailoring their investigations to yield clearer mechanistic insights.
Ultimately, integrating ATG12 Gene Knockout Cell Lines into your research toolbox enhances the potential for groundbreaking discoveries in cell biology and beyond. Our company specializes in high-quality, precisely engineered biological products, ensuring that researchers have access to the best resources to propel their investigations.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.